Ess Emm Pharma Private Limited - Company Profile

It is a pharma private limited company based in Panchkula, Haryana, India, established in 2020.
2020 Panchkula, Haryana, India Active
Last Updated:
About Ess Emm Pharma Private Limited

Ess Emm Pharma Private Limited, a active private limited company, was established on 19 August 2020 in Panchkula, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909HR2020PTC088455. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Siddharth Munshi (Director), Subash Munshi (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at B-1, Gh-42, Sector 20, Panchkula, Haryana, 134116.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909HR2020PTC088455

  • Registration Number

    088455

  • Incorporation Date

    19 August 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 274.72%
  • Profit Growth **** -43.03%
  • Ebitda **** -2.47%
  • Net Worth -183.70%
  • Total Assets -5.48%
Company report

Ess Emm Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ess Emm Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ess Emm Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddharth Munshi Director 19 Aug 2020 Current
Subash Munshi Director 19 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ess Emm Pharma.

Ess Emm Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 274.72% increase. The company also saw a substantial fall in profitability, with a 43.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 183.7%.

Ess Emm Pharma revenue growth over time
Ess Emm Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
274.72%
*******
*******
*******
*******
Revenue from Operations
*******
274.72%
*******
*******
*******
*******
Total Assets
*******
-5.48%
*******
*******
*******
*******
Profit or Loss
*******
-43.03%
*******
*******
*******
*******
Net Worth
*******
-183.70%
*******
*******
*******
*******
EBITDA
*******
-2.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ess Emm Pharma?

In 2021, Ess Emm Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ess Emm Pharma?

Ess Emm Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ess Emm Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ess Emm Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ess Emm Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ess Emm Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Ess Emm Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was documented.

  • Director Appointment

    The activity Siddharth Munshi was appointed as a Director was appointed as a Director on 19 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    The activity Subash Munshi was appointed as a Director was appointed as a Director on 19 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Company Incorporation

    Ess Emm Pharma Private Limited was registered on 19 Aug 2020 with Roc Delhi & aged 5 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ess Emm Pharma Private Limited?

The CIN of Ess Emm Pharma Private Limited is U51909HR2020PTC088455.

Where is Ess Emm Pharma Private Limited headquartered?

Ess Emm Pharma Private Limited is headquartered at B-1, Gh-42, Sector 20, Panchkula, Haryana, 134116.

When was Ess Emm Pharma Private Limited incorporated?

Ess Emm Pharma Private Limited was incorporated on 19 August 2020.

Who are the current directors of Ess Emm Pharma Private Limited?

The current directors of Ess Emm Pharma Private Limited are

What is the primary industry of Ess Emm Pharma Private Limited?

The primary industry of Ess Emm Pharma Private Limited is Trade.

Is Ess Emm Pharma Private Limited a listed company?

Ess Emm Pharma Private Limited is unlisted.

What is the capital structure of Ess Emm Pharma Private Limited?

The authorized capital of Ess Emm Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available